Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan M Weissman

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Protocols in Immunology|April 25, 2008
Solubilization of lymphocytesAllan M Weissman
Cancer Cell|May 6, 2008
How much REST is enough?Allan M Weissman
Cell Biochemistry and Biophysics|June 12, 2013
Ubiquitin and drug discovery: challenges and opportunitiesAllan M Weissman
Nature Reviews. Cancer|August 25, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisStanley Lipkowitz, Allan M Weissman
Developmental Cell|September 15, 2012
A ubiquitin-binding rhomboid protease aimed at ERADicationYien Che Tsai, Allan M Weissman
Nature Cell Biology|December 3, 2010
Working on a chain: E3s ganging up for ubiquitylationMeredith B Metzger, Allan M Weissman
FEBS Letters|August 31, 2011
Dissecting the diverse functions of the metastasis suppressor CD82/KAI1Yien Che Tsai, Allan M Weissman
Genes & Cancer|February 19, 2011
The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and CancerYien Che Tsai, Allan M Weissman
The EMBO Journal|July 16, 2013
Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligaseR Andrew Byrd, Allan M Weissman
Plos Biology|April 7, 2011
Ubiquitylation in ERAD: reversing to go forward?Yien Che Tsai, Allan M Weissman
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Protocols in Immunology|April 25, 2008
Solubilization of lymphocytesAllan M Weissman
Cancer Cell|May 6, 2008
How much REST is enough?Allan M Weissman
Cell Biochemistry and Biophysics|June 12, 2013
Ubiquitin and drug discovery: challenges and opportunitiesAllan M Weissman
Nature Reviews. Cancer|August 25, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisStanley Lipkowitz, Allan M Weissman
Developmental Cell|September 15, 2012
A ubiquitin-binding rhomboid protease aimed at ERADicationYien Che Tsai, Allan M Weissman
Nature Cell Biology|December 3, 2010
Working on a chain: E3s ganging up for ubiquitylationMeredith B Metzger, Allan M Weissman
FEBS Letters|August 31, 2011
Dissecting the diverse functions of the metastasis suppressor CD82/KAI1Yien Che Tsai, Allan M Weissman
Genes & Cancer|February 19, 2011
The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and CancerYien Che Tsai, Allan M Weissman
The EMBO Journal|July 16, 2013
Compact Parkin only: insights into the structure of an autoinhibited ubiquitin ligaseR Andrew Byrd, Allan M Weissman
Plos Biology|April 7, 2011
Ubiquitylation in ERAD: reversing to go forward?Yien Che Tsai, Allan M Weissman
Pageof 8